Zoetis Inc (N:ZTS)

Business Focus: Veterinary Drugs

May 12, 2024 11:15 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS
Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation...
May 08, 2024 10:23 am ET
Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets - Hagens Berman
Hagens Berman, a prominent national trial law firm, is urging investors who suffered substantial losses in Zoetis Inc. (NYSE: ZTS) to promptly report their losses here. Additionally, individuals with relevant knowledge who may assist in the...
May 07, 2024 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Zoetis, and Morgan Stanley and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zoetis Inc. (NYSE: ZTS), and Morgan Stanley (NYSE: MS). Our investigations concern whether these companies have violated the...
May 06, 2024 07:19 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS
NEW YORK, May 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
May 04, 2024 09:44 am ET
ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zoetis Inc. (NYSE: ZTS) resulting from allegations that Zoetis may have issued materially misleading...
May 02, 2024 04:09 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS
Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.    The investigation...
Apr 30, 2024 10:00 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 30, 2024 02:51 pm ET
Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets - Hagens Berman
Hagens Berman, a prominent national trial law firm, is urging investors who suffered substantial losses in Zoetis Inc. (NYSE: ZTS) to promptly report their losses here. Additionally, individuals with relevant knowledge who may assist in the...
Apr 30, 2024 12:39 pm ET
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. (NYSE: ZTS) resulting from allegations that Zoetis may have issued materially misleading...
Apr 28, 2024 06:30 pm ET
Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health
Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that t
Apr 27, 2024 12:37 pm ET
ROSEN, A LEADING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. (NYSE: ZTS) resulting from allegations that Zoetis may have issued materially misleading...
Apr 25, 2024 05:30 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 24, 2024 11:20 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS
Pomerantz LLP is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.    The investigation...
Apr 23, 2024 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Zoetis, and Morgan Stanley and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zoetis Inc. (NYSE: ZTS), and Morgan Stanley (NYSE: MS). Our investigations concern whether these companies have violated the...
Apr 23, 2024 02:49 pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. (NYSE: ZTS) resulting from allegations that Zoetis may have issued materially misleading...
Apr 22, 2024 03:20 pm ET
Zoetis (ZTS) Drops on Report that Arthritis Drugs May Sicken Pets – Hagens Berman
Hagens Berman urges Zoetis Inc. (NYSE: ZTS) investors who suffered substantial losses to submit your losses now and persons with knowledge who may be able to assist the investigation to contact its attorneys. Visit:...
Apr 22, 2024 04:00 am ET
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 21, 2024 06:00 am ET
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 19, 2024 02:43 pm ET
SHAREHOLDER ALERT: Zoetis Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Block & Leviton is investigating Zoetis, Inc. (NYSE: ZTS) for potential securities law violations. Investors who have lost money in their Zoetis, Inc. investment should contact the firm to learn more about how they might recover those losses. For...
Apr 19, 2024 02:01 pm ET
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. (NYSE: ZTS) resulting from allegations that Zoetis may have issued materially misleading...
Apr 19, 2024 04:00 am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 18, 2024 07:15 pm ET
ZTS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Zoetis Inc. (NYSE: ZTS) Investors with Losses to Contact the Firm
RADNOR, Pa., April 18, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Zoetis Inc. (NYSE: ZTS) ("Zoetis").
Apr 18, 2024 08:00 am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 16, 2024 10:15 pm ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 15, 2024 05:45 pm ET
Zoetis Inc. Being Investigated on Behalf of Zoetis Inc. Investors. Contact Levi & Korsinsky For Details.
NEW YORK, NY / ACCESSWIRE / April 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zoetis Inc. ("Zoetis Inc.") (NYSE:ZTS) concerning possible violations of federal securities laws.
Apr 15, 2024 05:03 pm ET
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zoetis Inc. (ZTS)
The law firm of Kirby McInerney LLP is investigating potential claims against Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). The investigation concerns whether Zoetis and/or certain of its officers have violated the federal securities laws...
Apr 15, 2024 03:51 pm ET
ZTS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Zoetis Inc. (NYSE: ZTS) Investors with Losses to Contact the Firm
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Zoetis Inc. (NYSE: ZTS) (“Zoetis”).
Apr 15, 2024 03:26 pm ET
ZTS LOSS ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zoetis Inc. (NYSE: ZTS) resulting from allegations that Zoetis may have issued materially misleading business information to the investing public.
Apr 15, 2024 11:30 am ET
Zoetis Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - ZTS
NEW YORK, NY / ACCESSWIRE / April 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zoetis Inc. ("Zoetis Inc.") (NYSE:ZTS) concerning possible violations of federal securities laws.
Apr 15, 2024 11:03 am ET
Zoetis (ZTS) Drops on Report that Arthritis Drugs May Sicken Pets – Hagens Berman
Hagens Berman urges Zoetis Inc. (NYSE: ZTS) investors who suffered substantial losses to submit your losses now and persons with knowledge who may be able to assist the investigation to contact its attorneys. Visit:...
Apr 15, 2024 11:00 am ET
Lost Money on Zoetis Inc.(ZTS)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / April 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zoetis Inc. ("Zoetis Inc.") (NYSE:ZTS) concerning possible violations of federal securities laws.
Apr 15, 2024 09:45 am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, April 15, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE: ZTS) for violations of the securities laws.
Apr 15, 2024 07:30 am ET
Zoetis Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - ZTS
NEW YORK, NY / ACCESSWIRE / April 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zoetis Inc. ("Zoetis Inc.") (NYSE:ZTS) concerning possible violations of federal securities laws.
Apr 15, 2024 07:00 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 13, 2024 09:00 pm ET
Zoetis Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Zoetis Inc. (ZTS)
NEW YORK, NY / ACCESSWIRE / April 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zoetis Inc. ("Zoetis Inc.") (NYSE:ZTS) concerning possible violations of federal securities laws.
Apr 13, 2024 08:00 pm ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 13, 2024 06:15 pm ET
Lost Money on Zoetis Inc. (ZTS)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / April 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zoetis Inc. ("Zoetis Inc.") (NYSE:ZTS) concerning possible violations of federal securities laws.
Apr 13, 2024 12:00 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) for violations of the securities laws.
Apr 12, 2024 09:00 pm ET
ZOETIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zoetis Inc. on Behalf of Zoetis Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) on behalf of Zoetis stockholders. Our investigation concerns whether...
Apr 12, 2024 08:20 pm ET
Zoetis (ZTS) Drops on Report that Arthritis Drugs May Sicken Pets – Hagens Berman
Hagens Berman urges Zoetis Inc. (NYSE: ZTS) investors who suffered substantial losses to submit your losses now and persons with knowledge who may be able to assist the investigation to contact its attorneys. Visit:...
Apr 12, 2024 05:15 pm ET
Zoetis Inc. (ZTS) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / April 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zoetis Inc. ("Zoetis Inc.") (NYSE:ZTS) concerning possible violations of federal securities laws.
Apr 12, 2024 03:06 pm ET
Zoetis, Inc. Investors: Company Investigated by the Portnoy Law Firm
​The Portnoy Law Firm advises Zoetis, Inc. (“Zoetis”) (NYSE: ZTS) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Zoetis investors that lost money on their...
Apr 12, 2024 02:29 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. (“Zoetis” or “the Company”) (NYSE: ZTS) for violations of the securities laws. The investigation...
Apr 12, 2024 10:30 am ET
SHAREHOLDER ALERT: Zoetis Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
Block & Leviton is investigating Zoetis, Inc. (NYSE: ZTS) for potential securities law violations. Investors who have lost money in their Zoetis, Inc. investment should contact the firm to learn more about how they might recover those losses. For...
Apr 12, 2024 10:13 am ET
Investigation into Zoetis Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations - What Shareholders Need to Know
Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Zoetis Inc. ("Zoetis” or "the Company") (NYSE: ZTS). We are looking into whether the Company or its executives failed to disclose vital...
Apr 01, 2024 04:30 pm ET
Zoetis Appoints Gavin D.K. Hattersley to its Board of Directors
Zoetis Inc. (NYSE: ZTS) today announced the appointment of Gavin D.K. Hattersley, President, Chief Executive Officer and Director of Molson Coors Beverage Company, to its Board of Directors.
Mar 28, 2024 08:30 am ET
Zoetis to Host Webcast and Conference Call on First Quarter 2024 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 2, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2024 financial results and respond to questions from financial analysts during the call.
Mar 05, 2024 08:30 am ET
Zoetis to Participate in the Barclays Global Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 8:30 a.m. ET.
Feb 21, 2024 08:30 am ET
Zoetis to Participate in the Bank of America Securities 2024 Animal Health Summit
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2024 Animal Health Summit on Thursday, February 29, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 11:40 a.m. ET.
Feb 13, 2024 07:00 am ET
Zoetis Reports Fourth Quarter and Full Year 2023 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2023 as well as provided full year guidance for 2024.
Feb 06, 2024 04:15 pm ET
Zoetis Declares Second Quarter 2024 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the second quarter of 2024. The dividend will be paid on Tuesday, June 4, 2024, to all holders of record of the Company’s common stock as of the close of business on Friday, April 19, 2024.
Jan 18, 2024 08:00 am ET
Zoetis Wins 2024 Catalyst Award
Zoetis Inc. (NYSE:ZTS) has been selected as a 2024 Catalyst Award recipient for its
Dec 28, 2023 08:30 am ET
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2023 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 13, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2023 financial results and respond to questions from financial analysts during the call.
Dec 21, 2023 08:30 am ET
Zoetis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 3:45 p.m. PT.
Dec 07, 2023 04:05 pm ET
Zoetis Declares First Quarter 2024 Dividend; Board Approves 15% Payment Increase
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the first quarter of 2024, an increase of 15% from the quarterly dividend rate paid in 2023. The dividend will be paid on Friday, March 1, 2024, to all holders of record of the Company’s common stock as of the close of business on Friday, January 19, 2024.
Nov 21, 2023 08:30 am ET
Zoetis to Participate in the Piper Sandler 35th Annual Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 1:00 p.m. ET.
Nov 02, 2023 07:00 am ET
Zoetis Announces Third Quarter 2023 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2023 and updated its guidance for full year 2023.
Oct 12, 2023 04:15 pm ET
Zoetis Declares Fourth Quarter 2023 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth quarter of 2023. The dividend will be paid on Friday, December 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Wednesday, November 1, 2023.
Oct 10, 2023 01:35 pm ET
Zoetis Named a 100 Best Company for Working Parents by Seramount
For the tenth year in a row, Zoetis, the world leader in animal health, has been named one of
Sep 27, 2023 08:30 am ET
Zoetis to Host Webcast and Conference Call on Third Quarter 2023 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 2, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2023 financial results and respond to questions from financial analysts during the call.
Sep 07, 2023 07:00 am ET
Zoetis Foundation Announces $2.6 Million in Grants to Advance Opportunities for Veterinarians and Livestock Farmers
Today, the Zoetis Foundation announced that it will distribute $2.6 million during its second round of 2023 grants, supporting six initiatives to help enable thriving professions and livelihoods for livestock farmers and veterinary professionals.
Sep 06, 2023 04:30 pm ET
Zoetis to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, Sept. 12, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 12:55 p.m. ET.
Aug 23, 2023 06:01 am ET
Media Advisory: Ribbon-cutting Ceremony for new Zoetis facility in Durham, N.C., to expand diagnostics R&D and engineering capabilities and bring more jobs to Durham
Zoetis, the world’s leading animal health company, is pleased to invite members of the media to attend a ribbon-cutting event to mark the official opening of a new building dedicated to diagnostics and biodevices research and development (R&D) to meet the needs of veterinarians, livestock farmers and pet owners. The expanded site will serve as the hub for Zoetis’ engineering and diagnostics work including device reliability testing. The new building features more than 78,000 square feet including 23,000 square feet of total lab space allotted for a biodevice engineering lab, biodevice science
Aug 17, 2023 03:00 pm ET
Media Advisory: Ribbon-cutting Ceremony for new Zoetis facility in Durham, N.C., to expand diagnostics R&D and engineering capabilities and bring more jobs to Durham
Zoetis, the world’s leading animal health company, is pleased to invite members of the media to attend a ribbon-cutting event to mark the official opening of a new building dedicated to diagnostics and biodevices research and development (R&D) to meet the needs of veterinarians, livestock farmers and pet owners. The expanded site will serve as the hub for Zoetis’ engineering and diagnostics work including device reliability testing. The new building features more than 78,000 square feet including 23,000 square feet of total lab space allotted for a biodevice engineering lab, biodevice science
Aug 09, 2023 09:00 am ET
Media Advisory: Ribbon Cutting Ceremony for new Zoetis facility in Lincoln, NE, to expand manufacturing capabilities and bring more jobs to Lincoln
Zoetis, the world’s leading animal health company, is pleased to invite members of the media to attend a ribbon-cutting event to mark the official opening of our new monoclonal antibodies (mAbs) expansion, which will enable the site to increase production of products that control osteoarthritis pain in dogs and cats – our largest growing area of need for pet care customers. The site will also be a home for future innovation and serve as a Veterinary Medicine R&D registration facility for the company.
Aug 08, 2023 07:00 am ET
Zoetis Announces Second Quarter 2023 Results
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the second quarter of 2023 and updated its guidance for full year 2023.
Aug 04, 2023 01:17 pm ET
Media Advisory: Ribbon Cutting Ceremony for new Zoetis facility in Lincoln, NE, to expand manufacturing capabilities and bring more jobs to Lincoln
Zoetis, the world’s leading animal health company, is pleased to invite members of the media to attend a ribbon-cutting event to mark the official opening of our new monoclonal antibodies (mAbs) expansion, which will enable the site to increase production of products that control osteoarthritis pain in dogs and cats – our largest growing area of need for pet care customers. The site will also be a home for future innovation and serve as a Veterinary Medicine R&D registration facility for the company.
Jul 12, 2023 08:00 am ET
Jul 10, 2023 08:00 am ET
Zoetis Announces Appointment of Ester Banque as President of U.S. Operations for World Leader in Animal Health
Zoetis Inc. (NYSE:ZTS) today announced the addition of Ester Banque as Executive Vice President and President, U.S. Operations, for the company, effective July 10, 2023. Ms. Banque is an accomplished global senior executive with over 30 years of experience in health sciences with top tier pharmaceutical companies. Ester will be a member of the Zoetis Executiv
Jun 30, 2023 08:30 am ET
Zoetis to Host Webcast and Conference Call on Second Quarter 2023 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Aug. 8, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review second quarter 2023 financial results and respond to questions from financial analysts during the call.
Jun 15, 2023 08:00 am ET
Zoetis Releases 2022 Sustainability Report to Share Progress in Building a Better Future for People, Animals and the Planet
Zoetis today published its 2022 Sustainability Report “Together We Are Making a Difference for a Better World”, describing the company’s progress toward achieving its Driven to Care long-term sustainability aspirations and continued disclosure on environmental, social
May 30, 2023 04:30 pm ET
Zoetis to Participate in the Stifel 2023 Jaws and Paws Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2023 Jaws and Paws Conference on Wednesday, May 31, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 3:35 p.m. ET.
May 25, 2023 07:30 am ET
Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade
Zoetis Inc. (NYSE:ZTS) is hosting an investor day at 9:00 a.m. ET today at the New York Stock Exchange, where the company will dive into its compelling growth ambitions, its innovative and robust R&D pipeline and its financial roadmap to continue delivering shareholder value, as it Shapes Animal Health for the Next Decade.
May 11, 2023 04:05 pm ET
Zoetis Declares Third Quarter 2023 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the third quarter of 2023. The dividend will be paid on Friday, September 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Friday, July 21, 2023.
May 05, 2023 03:44 pm ET
Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs
Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Librela™ (bedinvetmab injection) for the control of pain associated with osteoarthritis (OA) in dogs. Librela is the first and only once-monthly, anti-NGF monoclonal antibody treatment for canine OA pain and is approved as safe and effective in providing lo
May 04, 2023 07:00 am ET
Zoetis Announces First Quarter 2023 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2023 and maintained its guidance for full year 2023.
May 01, 2023 08:30 am ET
Zoetis Announces Date for 2023 Investor Day
Zoetis Inc. (NYSE:ZTS) will host an Investor Day on Thursday, May 25, 2023, at the New York Stock Exchange featuring Kristin Peck, Chief Executive Officer; Wetteny Joseph, Chief Financial Officer; Robert Polzer, Ph.D., President of Research and Development; and other members of the Zoetis executive team. Zoetis will provide an update on the company’s strategy
Apr 05, 2023 08:00 am ET
Zoetis Foundation Announces First Round of 2023 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Well-being
Today, the Zoetis Foundation announced that it will distribute $5.3 million during its first round of 2023 grants, supporting 21 initiatives impacting 15 countries to help enable thriving professions and livelihoods for livestock farmers and veterinary professionals, as well as relief efforts for those impacted by the earthquake in Türkiye.
Mar 30, 2023 08:30 am ET
Zoetis to Host Webcast and Conference Call on First Quarter 2023 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 4, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2023 financial results and respond to questions from financial analysts during the call.
Mar 13, 2023 08:00 am ET
Zoetis Named One of the World’s Most Ethical Companies by Ethisphere
Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the
Mar 03, 2023 08:30 am ET
Zoetis to Participate in the TD Cowen Health Care Conference
Zoetis Inc. (NYSE:ZTS) will participate in the TD Cowen Health Care Conference on Monday, March 6, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 11:10 a.m. ET.
Mar 01, 2023 07:00 am ET
Zoetis Secures $15.3 Million Grant to Advance Sustainable Livestock Production and Improve Livelihoods in Sub-Saharan Africa
Zoetis is pleased to receive a $15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate innovative solutions to advance veterinary care and diagnostic services that will ultimately improve livestock health and productivity in Sub-Saharan Africa. The grant will help Zoetis to expand its original African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative to include aquaculture in addition to cattle, poultry, and swine in an additional seven countries in Sub-Saharan Africa. Part of the company’s
Feb 28, 2023 08:30 am ET
Zoetis to Participate in the Bank of America Securities 2023 Animal Health Summit
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2023 Animal Health Summit on Thursday, March 2, 2023. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 12:30 p.m. ET.
Feb 14, 2023 07:00 am ET
Zoetis Reports Fourth Quarter and Full Year 2022 Results
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2022 and provided full year guidance for 2023.
Feb 08, 2023 04:10 pm ET
Zoetis Declares Second Quarter 2023 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the second quarter of 2023. The dividend will be paid on Thursday, June 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Friday, April 21, 2023.
Dec 22, 2022 08:30 am ET
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2022 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 14, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2022 financial results and respond to questions from financial analysts during the call.
Dec 21, 2022 08:30 am ET
Zoetis to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 1:30 p.m. PT.
Dec 08, 2022 04:05 pm ET
Zoetis Declares First Quarter 2023 Dividend; Board Approves 15% Payment Increase
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the first quarter of 2023, an increase of 15% from the quarterly dividend rate paid in 2022. The dividend will be paid on Wednesday, March 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Friday, January 20, 2023.
Nov 29, 2022 08:30 am ET
Zoetis to Participate in the Piper Sandler 34th Annual Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022. Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices, will represent the company and respond to questions from analysts. He is scheduled to present at 3:30 p.m. ET.
Nov 08, 2022 05:20 pm ET
Zoetis Announces Pricing of $1.35 Billion of Senior Notes
Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.35 billion of senior notes, consisting of $600 million aggregate principal amount of 5.400% senior notes due 2025 and $750 million aggregate principal amount of 5.600% senior notes due 2032, in an underwritten public offering.
Nov 03, 2022 07:00 am ET
Zoetis Announces Third Quarter 2022 Results 
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2022 and lowered its guidance for full year 2022 to reflect lower than expected sales due to continued supply constraints, veterinary workforce challenges, and the negative impact of recent changes to foreign exchange rates.
Oct 13, 2022 05:15 pm ET
Zoetis Declares Fourth Quarter 2022 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the fourth quarter of 2022. The dividend will be paid on Thursday, December 1, 2022, to all holders of record of the Company’s common stock as of the close of business on Tuesday, November 1, 2022.
Oct 10, 2022 08:53 am ET
Zoetis Named to Fortune’s 2022 Change the World List
Zoetis has been named to Fortune’s 2022 Change the World list, a global ranking of the top 50 companies making a positive social impact through business practices that are integral to their core corporate purpose. Zoetis’ inclusion on the list is based on the company’s African Livestock Productivi
Sep 30, 2022 07:00 am ET
Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products
Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals. Jurox’s operations are based in Australia, with additional regional offices in New Zealand, U.S., Canada and the UK. F
Sep 29, 2022 09:26 am ET
Zoetis to Host Webcast and Conference Call on Third Quarter 2022 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 3, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2022 financial results and respond to questions from financial analysts during the call.
Sep 20, 2022 01:24 pm ET
Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount
For the ninth year in a row, Zoetis has been named one of
Sep 09, 2022 08:30 am ET
Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:05 p.m. ET.
Aug 04, 2022 07:00 am ET
Zoetis Announces Second Quarter 2022 Results 
Zoetis Inc.(NYSE: ZTS) today reported its financial results for the second quarter of 2022 and updated its guidance for full year 2022 to reflect its positive outlook for the remainder of the year, as well as the negative impact of recent changes to foreign exchange rates.
Jul 25, 2022 05:00 pm ET
Zoetis Appoints Vanessa Broadhurst to its Board of Directors
Zoetis Inc. (NYSE: ZTS) today announced the appointment of Vanessa Broadhurst, Executive Vice President, Global Corporate Affairs at Johnson & Johnson, to its Board of Directors. Ms. Broadhurst has deep experience in consumer insights and direct-to-consumer advertising, and her appointment increases the size of the Board from 11 to 12 members. She
Jun 30, 2022 08:30 am ET
Zoetis to Host Webcast and Conference Call on Second Quarter 2022 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 4, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review second quarter 2022 financial results and respond to questions from financial analysts during the call.
Jun 22, 2022 08:30 am ET
Zoetis Completes Acquisition of Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions
Zoetis Inc. (NYSE:ZTS) today announced the completion of its acquisition of Basepaws, a privately held petcare genetics company, which provides pet owners with genetic tests, analytics and early health risk assessments. The genetic insights from Basepaws help pet owners and veterinarians understand an individual pet’s risk for disease and can lead to more meaningful engagements and increased likelihood of early detection and treatment of disease. The acquisition was first
Jun 10, 2022 08:30 am ET
Zoetis to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on Monday, June 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 4:20 p.m. ET (1:20 p.m. PT).
Jun 08, 2022 08:00 am ET
Zoetis Releases 2021 Sustainability Update to Share Progress in Championing Healthier Communities, Animals and the Planet
Zoetis today published its 2021 Sustainability Progress Update describing the company’s progress toward achieving its
Jun 07, 2022 08:30 am ET
Zoetis Announces Agreement to Acquire Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions
Zoetis Inc. (NYSE:ZTS) today announced an agreement to acquire Basepaws, a privately held petcare genetics company, which provides pet owners with genetic tests, analytics and early health risk assessments that can help manage the health, wellness and quality of care for their pets. The acquisition will advance Zoetis’ portfolio in the precision animal health
May 27, 2022 08:30 am ET
Zoetis to Participate in the Stifel 2022 Jaws and Paws Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2022 Jaws and Paws Conference on Wednesday, June 1, 2022. Glenn David, Executive Vice President and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance, will represent the company and respond to questions from analysts. He is scheduled to present at 4:10 p.m. ET.
May 19, 2022 04:10 pm ET
Zoetis Declares Third Quarter 2022 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the third quarter of 2022. The dividend will be paid on Thursday, September 1, 2022, to all holders of record of the Company’s common stock as of the close of business on Thursday, July 21, 2022.
May 05, 2022 07:00 am ET
Zoetis Announces First Quarter 2022 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2022 and updated its guidance for full year 2022 due to the negative impact of recent changes in foreign exchange rates. The updated guidance reflects the same operational growth rates for revenue and adjusted net income as stated in the company’s previous guidance for 20
Apr 12, 2022 08:00 am ET
Zoetis Foundation Announces First Round of 2022 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Wellness
Today, the Zoetis Foundation announced that it will distribute $4.9 million during its first round of 2022 grants, supporting 20 initiatives based in 19 countries to help enable thriving professions and livelihoods for livestock farmers and veterinary professionals as well as relief efforts in Ukraine.
Mar 31, 2022 08:30 am ET
Zoetis to Host Webcast and Conference Call on First Quarter 2022 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 5, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2022 financial results and respond to questions from financial analysts during the call.
Mar 11, 2022 08:30 am ET
Zoetis to Participate in the Barclays Global Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 17, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 9:30 a.m. ET.
Mar 09, 2022 08:00 am ET
Zoetis Named One of Most Innovative Companies in 2022 by Fast Company
Zoetis has been named to Fast Company’s list of Most Innovative Companies for 2022, ranking eighth in the corporate social responsibility category. Zoetis is the only stand-alone animal health company to be included on thi
Feb 22, 2022 04:30 pm ET
Zoetis to Participate in the Bank of America Securities 2022 Animal Health Summit
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2022 Animal Health Summit on Thursday, Feb. 24, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:30 p.m. ET.
Feb 15, 2022 07:00 am ET
Zoetis Reports Fourth Quarter and Full Year 2021 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2021 and provided full year guidance for 2022.
Feb 08, 2022 04:12 pm ET
Zoetis Declares Second Quarter 2022 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the second quarter of 2022. The dividend will be paid on Wednesday, June 1, 2022, to all holders of record of the Company’s common stock as of the close of business on Thursday, April 21, 2022.
Jan 13, 2022 01:36 pm ET
Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats
Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Solensia™ to control the pain of osteoarthritis (OA) in cats, helping improve their mobility, comfort and overall well-being.1 As a once-monthly injection administered in the veterinary clinic, Solensia keeps OA pain from disrup
Jan 06, 2022 08:00 am ET
Zoetis Announces Expanded Commitments to Protect the Planet
Zoetis Inc. (NYSE:ZTS), the world’s leading animal health company, has refreshed its Driven to Care sustainability aspirations for mitigating the company’s climate impact and environmental effects on the planet. Focusing first on its own operations, Zoetis is striving to achieve carbon neutrality by 2030. This includes accelerating the company’s commitment to Renewable Energy 100 (RE100) to use 100% renewable energy in its operations. The company’s updated commitments are underscored by investments in technology and a strong governance structure.
Dec 23, 2021 08:30 am ET
Zoetis to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 10, 2022. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 1:30 p.m. ET.
Dec 23, 2021 08:00 am ET
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2021 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 15, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2021 financial results and respond to questions from financial analysts during the call.
Dec 07, 2021 04:25 pm ET
Zoetis Announces Authorization of $3.5 Billion Share Repurchase Program
Zoetis Inc. (NYSE:ZTS) today announced that its Board of Directors has approved a $3.5 billion share repurchase program as part of its capital allocation plans. The shares are expected to be repurchased over a multi-year period, and the program can be cancelled at any time. The Company’s previous $2.0 billion share repurchase program, which was approved in Dec
Dec 02, 2021 12:50 pm ET
Zoetis Named One of Newsweek’s Most Responsible Companies for 2022
Zoetis has been named to Newsweek Magazine's America's Most Responsible Companies 2022 list, which recognizes top-performing companies that are making a difference through their environmental, social and corporate governance actions. The company debuted at #71 (out of 500 compan
Nov 04, 2021 07:00 am ET
Zoetis Announces Third Quarter 2021 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2021 and increased its guidance for full year 2021.
Oct 18, 2021 05:06 pm ET
Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health
Zoetis Inc. (NYSE:ZTS) today announced the appointment of Robert J. Polzer, PhD, as Executive Vice President and President of Research & Development for the company, effective Jan. 1, 2022. Polzer currently serves as Senior Vice President of Global Therapeutics for Zoetis and joined the company in 2015 after spending more than 20 years in R&D leadership roles at Pfizer. Polzer will become a member of the Zoetis Executive team and report to Chief Executive Officer Kristin Peck.
Oct 14, 2021 04:30 pm ET
Zoetis Declares Fourth Quarter 2021 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share. The dividend is to be paid on Wednesday, December 1, 2021, to holders of record on Friday, October 29, 2021.
Sep 30, 2021 09:25 am ET
Zoetis to Host Webcast and Conference Call on Third Quarter 2021 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 4, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2021 financial results and respond to questions from financial analysts during the call.
Sep 28, 2021 10:41 am ET
Zoetis Named a “100 Best Company” and a “Best Company for Dads” by Seramount
For the eighth year in a row, Zoetis has been named one of Seramount’s 100 Best Companies (previously known as the Working Mother 100 Best Companies list). The company was also named to Seramount’s
Sep 13, 2021 08:30 am ET
Zoetis to Participate in the Jefferies Virtual Pet Care Summit
Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies Virtual Pet Care Summit on Thursday, Sept. 16, 2021. Glenn David, Executive Vice President and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance, will represent the company and respond to questions from analysts. He is scheduled to present at 11:00 a.m. ET.
Aug 05, 2021 07:00 am ET
Zoetis Announces Second Quarter 2021 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the second quarter of 2021 and increased its guidance for full year 2021.
Aug 04, 2021 08:00 am ET
Zoetis to Acquire Jurox, a Leading Provider and Manufacturer of Livestock and Companion Animal Products
Zoetis Inc. (NYSE: ZTS) today announced it has entered into an agreement to acquire Jurox, a privately held animal health company, which develops, manufactures and markets a wide range of veterinary medicines for treating companion animals and livestock. Jurox’s operations are based in Australia, with additional regional offices and subsidiaries in New Zealan
Jul 02, 2021 08:30 am ET
Zoetis Donates COVID-19 Vaccines to Help Support the Health of Zoo Animals
Zoetis is donating more than 11,000 doses of its experimental COVID-19 vaccine to help protect the health and well-being of more than 100 mammalian species living in nearly 70 zoos, as well as more than a dozen conservatories, sanctuaries, academic institutions and government organizations located in 27 states. The vaccine has been authorized for experimental use on a case by case basis by the United States Department of Agriculture (USDA) and the appropriate state veterinarians. The vaccine deployment to dozens of zoos follows
Jun 30, 2021 08:30 am ET
Zoetis to Host Webcast and Conference Call on Second Quarter 2021 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 5, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review second quarter 2021 financial results and respond to questions from financial analysts during the call.
Jun 10, 2021 08:00 am ET
Zoetis A.L.P.H.A. Initiative Improves Livestock Health and Farmers’ Livelihoods in Sub-Saharan Africa with 1.7 billion Doses of Vaccines and Medicines administered in Four Years
Livestock health and farmers’ livelihoods have been dramatically improved in Sub-Saharan Africa, following the administration of 1.7 billion doses of vaccines and medicines and over 650,000 diagnostic tests through Zoetis’ African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative, now in its fourth year.
Jun 03, 2021 08:00 am ET
Zoetis Releases 2020 Sustainability Report and Creates the Zoetis Foundation, Marking Progress in Creating a Healthier Future for Communities, Animals and the Planet
Zoetis today published its 2020 Sustainability Report “Our Journey Toward a Better World” describing its commitment to continued disclosure on environmental, social and governance (ESG) topics and progress toward the company’s
May 27, 2021 08:30 am ET
Zoetis to Participate in the William Blair 41st Annual Growth Stock Conference
Zoetis Inc. (NYSE:ZTS) will participate in the William Blair 41st Annual Growth Stock Conference on Wednesday, June 2, 2021. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 12:20 p.m. ET.
May 24, 2021 08:30 am ET
Zoetis to Participate in the Stifel 2021 Virtual Jaws & Paws Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2021 Virtual Jaws & Paws Conference on Thursday, June 3, 2021. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 2:00 p.m. ET.
May 20, 2021 04:30 pm ET
Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2021 Dividend
Zoetis Inc. (NYSE:ZTS) today announced the results of shareholder voting at its 2021 Annual Meeting of Shareholders and provided details on its third quarter 2021 dividend.
May 11, 2021 07:00 am ET
Zoetis Announces Appointment of Glenn David as Group President and Wetteny Joseph as Executive Vice President and Chief Financial Officer
Zoetis Inc. (NYSE:ZTS) today announced leadership changes that will accelerate its long-term growth strategy in key markets and add new talent to its executive team. Glenn David, Executive Vice President and Chief Financial Officer (CFO) for Zoetis, has been named Executive Vice President and Group President, overseeing International Operations and other business units, effective June 1, 2021. In addition, the company announced Wetteny Joseph will join Zoetis as Executive Vice President and Chief Financial Officer, reporting to CEO Kristin Peck, and assume responsibility for the oversight of t
May 06, 2021 07:00 am ET
Zoetis Announces First Quarter 2021 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2021 and increased its guidance for full year 2021.
Mar 31, 2021 08:30 am ET
Zoetis to Host Webcast and Conference Call on First Quarter 2021 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 6, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review first quarter 2021 financial results and respond to questions from financial analysts during the call.
Mar 10, 2021 08:30 am ET
Zoetis Launches “Driven to Care” Sustainability Initiative and Long-Term Goals to Meet Commitments to Communities, Animals and the Planet
Zoetis Inc. (NYSE:ZTS) today announced its long-term sustainability goals, which build on the company’s purpose to nurture the world and humankind by advancing care for animals. Under the banner Driven to Care, Zoetis brings to life its specific commitments to Communities, Animals and the Planet, including support of 10 of the
Feb 24, 2021 08:30 am ET
Zoetis to Participate in the Cowen 41st Annual Health Care Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Cowen 41st Annual Health Care Conference on Monday, March 1, 2021. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 1:20 p.m. ET.
Feb 22, 2021 08:30 am ET
Zoetis to Participate in the Bank of America Securities 2021 Animal Health Summit Virtual Forum
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2021 Animal Health Summit Virtual Forum on Thursday, Feb. 25, 2021. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 7:50 a.m. ET.
Feb 22, 2021 03:00 am ET
Zoetis Receives European Commission Marketing Authorization for Solensia® (frunevetmab), a New Therapy for Feline Osteoarthritis Pain
Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the marketing authorization for Solensia® (frunevetmab), a new feline osteoarthritis treatment to alleviate pain. Osteoarthritis in cats is a very prevalent condition1, existing in 40% of cats, and may generate pain and limit a cat’s comfort and quality of li
Feb 16, 2021 07:00 am ET
Zoetis Reports Fourth Quarter and Full Year 2020 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2020 and provided full year guidance for 2021.
Feb 10, 2021 05:14 pm ET
Zoetis Declares Second Quarter 2021 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a second quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share. The dividend is to be paid on Tuesday, June 1, 2021, to holders of record on Wednesday, April 21, 2021.
Feb 09, 2021 11:07 am ET
Forbes Names Zoetis One of America’s Best Midsize Employers
Zoetis Inc. (NYSE: ZTS), the global leader in animal health, today announced that it has been named one of
Jan 28, 2021 10:00 am ET
Zoetis Scores 100% on 2021 Corporate Equality Index
Zoetis Inc. (NYSE: ZTS) today announced that it received a score of 100 percent on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index (CEI), the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ workplace equality. This is the first time Zoetis participated in the CEI and
Dec 30, 2020 08:30 am ET
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2020 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 16, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review fourth quarter and full year 2020 financial results and respond to questions from financial analysts during the call.
Dec 18, 2020 08:30 am ET
Zoetis to Participate in the 39th Annual J.P. Morgan Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the 39th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 11, 2021. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 10:00 a.m. ET.
Dec 09, 2020 04:30 pm ET
Zoetis Declares First Quarter 2021 Dividend; Board Approves 25% Payment Increase
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2021 dividend payable to holders of the company’s common stock of $0.25 per share, an increase of 25% from the quarterly dividend rate paid in 2020. The dividend is to be paid on Monday, March 1, 2021, to holders of record on Wednesday, January 20, 2021.
Dec 08, 2020 04:30 pm ET
Zoetis Appoints Tonie Leatherberry to Its Board of Directors
Zoetis Inc. (NYSE:ZTS) today announced the appointment of Antoinette (Tonie) Leatherberry, an experienced technology strategist and executive, to its Board of Directors. Her appointment increases the size of the Board from 12 to 13 members, and she will serve on the Board’s Audit and Corporate Governance Committees.
Dec 01, 2020 09:35 am ET
Zoetis Named One of the “Top 75 Companies for Executive Women” by Working Mother Media
Zoetis Inc. (NYSE:ZTS) today announced that it has been named one of the
Nov 16, 2020 08:00 am ET
Zoetis is First Animal Health Company to Issue Environmental, Social and Governance (ESG) Review Based on Leading Sustainability Frameworks
Zoetis (NYSE:ZTS) today announced publication of its 2019 Environmental, Social and Governance (ESG) Review, providing more information on its ESG initiatives, including disclosures on energy, waste and workforce metric
Nov 12, 2020 08:00 am ET
Zoetis Receives European Commission Marketing Authorization for Librela® (bedinvetmab)
Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the company marketing authorization for Librela (bedinvetmab), the first injectable monoclonal antibody (mAb) therapy approved in the European Union for monthly alleviation of osteoarthritis (OA) pain in dogs. Librela provides veterinarians a new treatment option, which effectively
Nov 05, 2020 07:00 am ET
Zoetis Announces Third Quarter 2020 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2020 and increased its guidance for full year 2020.
Oct 26, 2020 08:30 am ET
Zoetis to Participate in the Credit Suisse 2020 Virtual Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Credit Suisse 2020 Virtual Healthcare Conference on Tuesday, Nov. 10, 2020. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 11:00 a.m. ET.
Oct 07, 2020 04:33 pm ET
Zoetis Declares Fourth Quarter 2020 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2020 dividend payable to holders of the company’s common stock of $0.20 per share. The dividend is to be paid on Tuesday, Dec. 1, 2020, to holders of record on Wednesday, Oct. 21, 2020.
Sep 30, 2020 08:30 am ET
Zoetis to Host Webcast and Conference Call on Third Quarter 2020 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 5, 2020. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review third quarter 2020 financial results and respond to questions from financial analysts during the call.
Sep 15, 2020 10:40 am ET
Zoetis Named a Top Company for Working Mothers
Zoetis Inc. (NYSE: ZTS) today announced that it has been named one of Working Mother magazine’s
Sep 10, 2020 08:30 am ET
Zoetis to Participate in the 18th Annual Morgan Stanley Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the 18th Annual Morgan Stanley Healthcare Conference on Wednesday, Sept. 16, 2020. Kristin Peck, Chief Executive Officer, and Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. They are scheduled to present virtually at 8:00 a.m. ET.
Aug 06, 2020 07:00 am ET
Zoetis Announces Second Quarter 2020 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the second quarter of 2020 and raised and narrowed its guidance for full year 2020 to reflect the company’s current view of the estimated full-year impact of the COVID-19 pandemic and foreign currency headwinds.
Jul 07, 2020 07:06 am ET
Trianni and Zoetis Announce Agreement to Develop a Transgenic Antibody Discovery Platform for Use in Animal Health
SOUTH SAN FRANCISCO, Calif. and PARSIPPANY, N.J., July 7, 2020 /PRNewswire/ -- Trianni, Inc. (TRIANNI) and Zoetis (NYSE: ZTS) today announced a collaboration for the development of transgenic monoclonal antibody platforms for the discovery of new veterinary treatments.
Jun 26, 2020 08:30 am ET
Zoetis to Host Webcast and Conference Call on Second Quarter 2020 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 6, 2020. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review second quarter 2020 financial results and respond to questions from financial analysts during the call.
Jun 08, 2020 08:30 am ET
Zoetis to Participate in the William Blair 40th Annual Growth Stock Conference
Zoetis Inc. (NYSE:ZTS) will participate in the William Blair 40th Annual Growth Stock Conference on Thursday, June 11, 2020. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 12:20 p.m. ET (11:20 a.m. CT).
May 20, 2020 04:30 pm ET
Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2020 Dividend
Zoetis Inc. (NYSE:ZTS) today announced the results of shareholder voting at its 2020 Annual Meeting of Shareholders and provided details on its third quarter 2020 dividend.
May 18, 2020 08:30 am ET
Zoetis to Participate in the Stifel 2020 Virtual Jaws & Paws Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2020 Virtual Jaws & Paws Conference on Wednesday, May 27, 2020. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 12:40 p.m. ET.
May 07, 2020 08:45 pm ET
Zoetis Announces Pricing of $1.25 Billion of Senior Notes
Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.25 billion of senior notes, consisting of $750 million aggregate principal amount of 2.000% senior notes due 2030 and $500 million aggregate principal amount of 3.000% senior notes due 2050, in an underwritten public offering.
May 06, 2020 07:00 am ET
Zoetis Announces First Quarter 2020 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2020 and lowered its guidance for full year 2020 to reflect the company’s current view of the estimated full-year impact of the COVID-19 outbreak, recessionary conditions in the global economy, and foreign currency headwinds.
Apr 30, 2020 08:01 am ET
Innovative New Pet Health Start-up, Pumpkin Insurance Services, Launches in the U.S.
Pumpkin Insurance Services, Inc. (“Pumpkin”), a new pet insurance agency and pe
Apr 17, 2020 04:30 pm ET
Zoetis Recommends Stockholders Reject Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
Zoetis Inc. (NYSE: ZTS) has been notified of an unsolicited “mini-tender offer” by TRC Capital Investment Corporation (“TRC”) to purchase up to 1,000,000 shares of Zoetis common stock, representing approximately 0.21% of the outstanding shares of Zoetis common stock.
Apr 01, 2020 08:30 am ET
Zoetis to Host Webcast and Conference Call on First Quarter 2020 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Wednesday, May 6, 2020. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review first quarter 2020 financial results and respond to questions from financial analysts during the call.
Mar 03, 2020 10:55 am ET
Zoetis Named a Top Company for Executive Women by NAFE
Zoetis Inc. (NYSE: ZTS) today announced that it has been named one of the 2020
Feb 27, 2020 02:00 pm ET
Zoetis Receives FDA Approval for Simparica Trio™, A New Combination Parasite Preventative for Dogs
Zoetis today announced that the U.S. Food and Drug Administration (FDA) has approved Simparica TrioTM (sarolaner, moxidectin, and pyrantel chewable tablets), the first once-monthly, chewable tablet in the U.S. that delivers all-in-one protection from heartworm disease, ticks and fleas, roundworms and hookworms. This combinatio
Feb 21, 2020 08:30 am ET
Zoetis to Participate in the Cowen and Company 40th Annual Health Care Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020, in Boston, Mass. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 2:10 p.m. ET.
Feb 13, 2020 07:00 am ET
Zoetis Reports Fourth Quarter and Full Year 2019 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2019 and provided full year guidance for 2020.
Feb 11, 2020 04:36 pm ET
Zoetis Declares Second Quarter 2020 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a second quarter 2020 dividend payable to holders of the company’s common stock of $0.20 per share. The dividend is to be paid on Monday, June 1, 2020, to holders of record on Friday, April 17, 2020.
Feb 10, 2020 08:30 am ET
Zoetis to Participate in the Bank of America Merrill Lynch Animal Health Summit
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Animal Health Summit on Monday, Feb. 24, 2020, in New York, N.Y. Glenn David, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 8:40 a.m. ET.
Feb 07, 2020 04:30 pm ET
Zoetis Acquires Ethos Diagnostic Science, a Veterinary Reference Lab Business, to Further Expand its Comprehensive Diagnostics Capabilities
Zoetis Inc. (NYSE:ZTS) today announced the acquisition of Ethos Diagnostic Science, a veterinary reference lab business dedicated to serving leading specialty animal hospitals, the greater veterinary community and researchers with accurate, reliable results. Having entered the veterinary reference laboratory space through the acquisitions of both Phoenix Lab a
Jan 02, 2020 08:30 am ET
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2019 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Feb. 13, 2020. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review fourth quarter and full year 2019 financial results and respond to questions from financial analysts during the call.
Dec 18, 2019 08:30 am ET
Zoetis to Participate in the 38th Annual J.P. Morgan Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2020, in San Francisco, Calif. Kristin Peck, who will become Chief Executive Officer of Zoetis on January 1, 2020, will represent the company and respond to questions from analysts. She is scheduled to present at 7:00 p.m. ET (4:00 p.m. PT).
Dec 11, 2019 04:22 pm ET
Zoetis Declares First Quarter 2020 Dividend; Board Approves 22% Payment Increase
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a first quarter 2020 dividend payable to holders of the company’s common stock of $0.20 per share, an increase of 22% from the quarterly dividend rate paid in 2019. The dividend is to be paid on Tuesday, March 3, 2020, to holders of record on Friday, January 17, 2020.
Nov 22, 2019 08:00 am ET
Zoetis Acquires ZNLabs, a Nationwide Veterinary Reference Laboratory, to Further Strengthen its Comprehensive Diagnostics Portfolio
Zoetis Inc. (NYSE:ZTS) today announced the acquisition of ZNLabs, a full-service veterinary clinical reference laboratory company with a network of labs across the U.S. This follows Zoetis’ recent acquisition of Phoenix Lab as its entry into reference laboratory services and builds on a strategy to develop a more comprehensive diagnostics offering with enhanced value for vet
Nov 07, 2019 07:00 am ET
Zoetis Announces Third Quarter 2019 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2019 and updated its guidance for full year 2019.
Oct 31, 2019 04:30 pm ET
Zoetis Completes Acquisition of Phoenix Lab, a Leading Veterinary Reference Laboratory, to Enhance its Comprehensive Offering in Veterinary Diagnostics
Zoetis Inc. (NYSE:ZTS) today announced the completion of the acquisition of Phoenix Central Laboratory for Veterinarians, Inc. (Phoenix Lab), a full service veterinary reference laboratory company, after fulfilling all closing requirements. With the addition of reference laboratory services, Zoetis now can provide more comprehensive diagnostics products and services as an en
Oct 22, 2019 08:30 am ET
Zoetis to Participate in the Credit Suisse 28th Annual Healthcare Conference
Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.
Oct 03, 2019 04:15 pm ET
Zoetis Declares Fourth Quarter 2019 Dividend
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a fourth quarter 2019 dividend payable to holders of the company’s common stock of $0.164 per share. The dividend is to be paid on Monday, Dec. 2, 2019, to holders of record on Tuesday, Oct. 22, 2019.
Oct 03, 2019 07:15 am ET
Zoetis Names Kristin Peck to Succeed Juan Ramón Alaix as CEO on January 1, 2020
Zoetis Inc. (NYSE: ZTS) today announced that Kristin Peck will succeed Juan Ramón Alaix as Chief Executive Officer, effective January 1, 2020, and join the Board of Directors, effective immediately. Alaix, who has been CEO of Zoetis since its formation in 2012, has decided to retire as CEO effective December 31, 2019. He will act as an advisor on the leadership transition through December 31, 2020.
Oct 01, 2019 01:54 pm ET
Simparica Trio™, a Once-Monthly Triple Combination Antiparasitic Medication for Dogs, receives Notice of Compliance from Health Canada's Veterinary Drugs Directorate
Gives veterinarians a new choice for the treatment of external and internal parasitic infestations Treats and has persistent efficacy against ticks and fleas for one month Treats gastrointestinal nematodes Prevents heartworm disease (Dirofilaria immitis) KIRKLAND, QC, Oct. 1, 2019 /CNW Telbec/ - Zoetis Inc. (NYSE: ZTS) today announces that Simparica Trio™, a once-monthly triple combination antiparasitic medication for dogs, receives Notice of Compliance from Health Canada's Veterinary Drugs Directorate. 
Sep 30, 2019 08:30 am ET
Zoetis to Host Webcast and Conference Call on Third Quarter 2019 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 7, 2019. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Glenn David will review third quarter 2019 financial results and respond to questions from financial analysts during the call.
Sep 24, 2019 10:30 am ET
Zoetis Named a Top Company for Working Mothers
“We are honored to be building a legacy as a consistent member of Working Mother magazine’s top companies,” said Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications at Zoetis. “This recognition is a testament to the policies, programs and supportive culture we have established at Zoetis. Our colleagues are empowered to take on challenges and experiences that help them reach their career goals and aspirations, while maintaining healthy and fulfilling personal lives.”
Sep 20, 2019 09:00 am ET
European Commission Grants Marketing Authorisation to Simparica Trio™, a Once-Monthly Triple Combination Antiparasitic Medication for Dogs
Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted marketing authorisation for Simparica Trio™ (sarolaner/moxidectin/pyrantel) chewable tablets, a once-monthly triple combination antiparasitic medication for dogs with, or at risk from, mixed external and internal parasitic infestations. The granting of the marketing authorisation follows a pos
Sep 09, 2019 04:30 pm ET
Zoetis Scientists Present Positive Efficacy Data for Investigational Triple Combination Parasiticide at American Heartworm Society Meeting
Zoetis Inc. today announced that its scientists presented positive efficacy data for the company’s investigational, triple combination parasiticide product at the 2019 Triennial meeting of the American Heartworm Society (AHS) in New Orleans, La. Zoetis is developing a triple combination product containing sarolaner, moxidectin and pyrantel that is administered orally once
Sep 04, 2019 08:30 am ET
Zoetis to Participate in the Bank of America Merrill Lynch Global Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Merrill Lynch Global Healthcare Conference on Thursday, Sept. 19, 2019, in London, England. Clint Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics, will represent the company and respond to questio
Aug 15, 2019 08:30 am ET
Zoetis to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, Sept. 10, 2019, in New York, N.Y. Glenn David, Executive Vice President and Chief Financial Officer, and Kristin Peck, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, will represent the company and respond to qu
Aug 14, 2019 08:30 am ET
Zoetis Completes Acquisition of Platinum Performance, a Leading Nutrition-Focused Animal Health Business
Zoetis Inc. (NYSE: ZTS) today announced the completion of the acquisition of Platinum Performance, a privately-held nutrition-focused animal heath company, after fulfilling all closing requirements. The acquisition was first announced on
Aug 06, 2019 07:00 am ET
Zoetis Announces Second Quarter 2019 Results
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the second quarter of 2019 and raised its guidance for full year 2019.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.